Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03116139 · ClinicalTrials.gov registry record · NA
Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 253
- Enrollment target
NCT03116139 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 253 participants.
The verdict
NCT03116139, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 253 participants
- Enrollment target
Study Summary
Both, CT scans and VQ scans, are used by doctors to look for pulmonary embolism. The most common reason to order a VQ scan is to avoid the IV dye. The IV dye used for CT scans can cause kidney problems in some patients, called contrast-induced nephropathy or "CIN." This is a kidney problem that usually does not make patients feel any differently or change how they urinate. Most of the time, it can only be found by testing blood several days later. This kind of kidney problem can be very mild and some patients will never have any symptoms, rarely these problems can be severe. Some patients can also have similar kidney problems for many other reasons (reactions to medications, blood pressure problems, etc.) and can even happen in patients that do not get IV dye. That is why doctors are not sure exactly who will have these problems or if using a test that does not use IV dye can prevent this kidney problem. The VQ scan uses a different medication through the IV that is not IV dye and has not been linked to kidney problems. The purpose of this study is to learn if using the test that does not use IV dye (the "VQ scan") instead of a CT scan in some patients can help to prevent kidney problems.
Interventions
- DIAGNOSTIC_TEST V/Q imaging
- DIAGNOSTIC_TEST Computed tomography scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2017-07-20 |
| Est. Completion | 2024-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03116139
The ClinicalTrials.gov registry entry for NCT03116139 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which V/Q imaging is the first listed.
NCT03116139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03116139 about?
NCT03116139 is a clinical study titled "Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT". Both, CT scans and VQ scans, are used by doctors to look for pulmonary embolism. The most common reason to order a VQ scan is to avoid the IV dye. The IV dye used for CT scans can cause kidney problems in some patients, called contrast-induced nephropathy or "CIN." This is a kidney problem that usua...
What is the current status of trial NCT03116139?
This trial is currently terminated. It is a NA study. The enrollment target is 253 participants. The study started on 2017-07-20. Estimated completion is 2024-03-27.
What interventions are being tested in trial NCT03116139?
The interventions under investigation include: V/Q imaging (DIAGNOSTIC_TEST), Computed tomography scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03116139?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.